What is Cloacina?
Cloacina operates as a specialized manufacturer of stainless steel package wastewater treatment plants and advanced equipment. With a legacy spanning four generations of licensed wastewater professionals, the firm provides critical infrastructure solutions including Membrane Bioreactors, Aerated Sludge Handling Systems, and Primary Treatment Systems. Their market position is defined by a focus on durability and regulatory compliance, serving a diverse clientele that encompasses municipal entities, wineries, food and beverage processors, and large-scale engineering developers. As a family-owned enterprise, Cloacina integrates deep technical expertise with modular engineering to address the complex water management challenges faced by modern industrial and public sector clients.
How much funding has Cloacina raised?
Cloacina has raised a total of $762K across 2 funding rounds:
Debt
$350K
Debt
$412K
Debt (2020): $350K with participation from PPP
Debt (2021): $412K led by PPP
Key Investors in Cloacina
PPP
Public-Private Partnership
What's next for Cloacina?
With the infusion of this recent capital, Cloacina is expected to scale its operational capacity to meet the rising demand for sustainable water treatment technologies. The strategic roadmap likely involves enhancing manufacturing throughput and investing in R&D to refine its proprietary treatment systems. As the company transitions through this phase of enterprise-level growth, it will likely focus on deepening its penetration into the municipal and industrial sectors, where the need for reliable, long-lasting wastewater infrastructure remains a high priority. The firm's ability to maintain its family-operated ethos while scaling its technical output will be a key determinant in its long-term market dominance and competitive positioning.
See full Cloacina company page
